|
IL184955A0
(en)
|
|
Tricyclic-nucleoside compounds for treating viral infections
|
|
IL184242A0
(en)
|
|
Indole derivatives for treating viral infections
|
|
IL250858A0
(en)
|
|
Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
|
|
PL1853251T3
(en)
|
|
Halogen-substituted boronophthalides for the treatment of infections
|
|
WO2008115281A3
(en)
|
|
Compounds for treating viral infections
|
|
AU2005235116A1
(en)
|
|
Combinations for treating HIV infection
|
|
GB0308603D0
(en)
|
|
Pharmaceutical combinations for treating viral infections
|
|
HK1070813A
(en)
|
|
Pharmaceutical combinations for treating viral infections
|
|
IL186059A0
(en)
|
|
Carbapenem derivatives and processes for the preparation thereof
|
|
GB0308604D0
(en)
|
|
Pharmaceutical combinations for treating viral infections
|
|
HK1115138A
(en)
|
|
Tricyclic-nucleoside compounds for treating viral infections
|
|
HK1115139A
(en)
|
|
Tricyclic-nucleoside prodrugs for treating viral infections
|
|
HK1108894A
(en)
|
|
Indole derivatives for treating viral infections
|
|
AU2005906415A0
(en)
|
|
Treatment for tendinopathy
|
|
AU2005904337A0
(en)
|
|
Pharmaceutical process
|
|
AU2005901541A0
(en)
|
|
Pharmaceutical process
|
|
GB0517835D0
(en)
|
|
DNA viral infections
|
|
AU2005904004A0
(en)
|
|
Compounds for medicinal treatment
|
|
AU2005902412A0
(en)
|
|
Medicinal treatment
|
|
HK1126968A
(en)
|
|
Statins for the treatment of viral influenza infections
|
|
HK1115809A
(en)
|
|
Pharmaceutical composition
|
|
HK1116830A
(en)
|
|
Rnai therapeutic for respiratory virus infection
|
|
HK1143158A
(en)
|
|
Treating and preventing viral infections
|
|
GB0616451D0
(en)
|
|
Dna viral infections
|
|
HK1133040A
(en)
|
|
Improved fix-mutant proteins for hemophilia b treatment
|